| scholarly article | Q13442814 |
| P50 | author | Lewis Kuller | Q88077314 |
| P2093 | author name string | W S Browner | |
| J A Cauley | |||
| L Lucas | |||
| S Cummings | |||
| P2860 | cites work | Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study | Q71697421 |
| A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women | Q71974059 | ||
| Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer | Q71985994 | ||
| Visceral obesity and breast cancer risk | Q72065077 | ||
| A case-control interview study of breast cancer among Japanese A-bomb survivors. II. Interactions with radiation dose | Q72384603 | ||
| Black-white differences in serum sex hormones and bone mineral density | Q72410622 | ||
| The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients | Q72520126 | ||
| Reproductive correlates of bone mass in elderly women. Study of Osteoporotic Fractures Research Group | Q72540546 | ||
| Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer | Q24685693 | ||
| Hormone therapy to prevent disease and prolong life in postmenopausal women | Q34262585 | ||
| Hormone replacement and cancer | Q35543135 | ||
| Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence | Q35644167 | ||
| Potential role of tamoxifen in prevention of breast cancer | Q37389091 | ||
| Western diet and Western diseases: some hormonal and biochemical mechanisms and associations | Q37899043 | ||
| Epidemiology and natural history of breast cancer. Implications for the body weight-breast cancer controversy | Q37941745 | ||
| Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women | Q38480036 | ||
| Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). | Q38510136 | ||
| Reproductive endocrinologic alterations in female asymptomatic obesity | Q38710165 | ||
| A prospective study of endogenous estrogens and breast cancer in postmenopausal women | Q39378468 | ||
| Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer. | Q39509220 | ||
| Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways | Q39738198 | ||
| The regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins. | Q40384678 | ||
| Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus | Q40406973 | ||
| The clinical biochemistry of the menopause and hormone replacement therapy | Q40606321 | ||
| Sex steroids and breast cancer prevention. | Q40654486 | ||
| Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk | Q40862149 | ||
| Nipple aspirate fluid in epidemiologic studies of breast disease | Q40862161 | ||
| The etiology of breast cancer--from epidemiology to prevention | Q40933851 | ||
| Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group | Q41189218 | ||
| Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group | Q43994565 | ||
| Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group | Q44331500 | ||
| Weight gain at the time of menopause | Q47435739 | ||
| Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort | Q48960509 | ||
| Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. | Q50597604 | ||
| Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. | Q51006975 | ||
| Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. | Q51593237 | ||
| Prevalence and determinants of estrogen replacement therapy in elderly women. | Q52865784 | ||
| Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene | Q64383038 | ||
| Menstrual factors and risk of breast cancer | Q67927017 | ||
| Reliability and interrelations among serum sex hormones in postmenopausal women | Q68174452 | ||
| Relationship of endogenous sex steroid hormones to lipids and apoproteins in postmenopausal women | Q68366743 | ||
| Evidence of estrogen receptors in normal human osteoblast-like cells | Q68424951 | ||
| Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood | Q68830464 | ||
| Bone mass and its relationship to age and the menopause | Q69400488 | ||
| Estrogen receptor variants in normal human mammary tissue | Q71039783 | ||
| P304 | page(s) | 593-599 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | Environmental Health Perspectives | Q1345904 |
| P1476 | title | Sex steroid hormones, bone mineral density, and risk of breast cancer | |
| P478 | volume | 105 Suppl 3 |
| Q33903214 | Adolescent diet and subsequent serum hormones, breast density, and bone mineral density in young women: results of the Dietary Intervention Study in Children follow-up study |
| Q44842659 | Bone mass density and risk of breast cancer and survival in older women |
| Q81251000 | Bone mass density, subsequent risk of colon cancer and survival in postmenopausal women |
| Q42273295 | Bone mineral density and breast cancer risk: Results from the Vorarlberg Health Monitoring & Prevention Program and meta-analysis. |
| Q45966605 | Breast cancer and bone mass in older women: is bone density prescreening for mammography useful? |
| Q77357663 | Breast cancer and hormone replacement therapy |
| Q34224822 | Breast cancer: hormones and other risk factors |
| Q33695020 | Estrogen, alcohol and breast cancer risk |
| Q34132661 | Estrogens and women's health: interrelation of coronary heart disease, breast cancer and osteoporosis |
| Q64994804 | High Bone Mineral Density of the Lumbar Spine Is Positively Associated with Breast Cancer. |
| Q33698099 | Hormone replacement therapy: the perspectives for the 21st century |
| Q33679258 | Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility |
| Q25257712 | Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study |
Search more.